Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data.

Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, Chang AR, Inker LA, Kenealy T, Kovesdy CP, Lee BJ, Levin A, Naimark D, Pena MJ, Schold JD, Shalev V, Wetzels JFM, Woodward M, Gansevoort RT, Levey AS, Coresh J.

J Am Soc Nephrol. 2019 Jul 10. pii: ASN.2019010008. doi: 10.1681/ASN.2019010008. [Epub ahead of print]

PMID:
31292199
2.

Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes.

Mulder S, Heerspink HJL, Darshi M, Kim JJ, Laverman GD, Sharma K, Pena MJ.

Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13823. [Epub ahead of print]

PMID:
31264758
3.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH; DIPAK-1 Investigators.

Gastroenterology. 2019 Apr 22. pii: S0016-5085(19)36711-3. doi: 10.1053/j.gastro.2019.04.018. [Epub ahead of print]

PMID:
31022403
4.

Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers.

Idzerda NMA, Stefansson BV, Pena MJ, Sjostrom DC, Wheeler DC, Heerspink HJL.

Nephrol Dial Transplant. 2019 Apr 21. pii: gfz064. doi: 10.1093/ndt/gfz064. [Epub ahead of print]

PMID:
31005993
5.

Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review.

Lutfiana NC, van Boven JFM, Masoom Zubair MA, Pena MJ, Alffenaar JC.

Br J Clin Pharmacol. 2019 Jul;85(7):1407-1417. doi: 10.1111/bcp.13935. Epub 2019 May 17. Review.

6.

Acute effect of an amino acid mixture in the rat glycemic profile.

Pena MJ, Guerreiro SG, Rocha JC, Morais T, Pereira SS, Monteiro MP, Borges N.

J Cell Biochem. 2019 Aug;120(8):13056-13065. doi: 10.1002/jcb.28576. Epub 2019 Mar 14.

PMID:
30873675
7.

Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible.

Pena MJ, Chueca N, D'Avolio A, Zarzalejos JM, Garcia F.

Open Forum Infect Dis. 2018 Dec 10;6(1):ofy332. doi: 10.1093/ofid/ofy332. eCollection 2019 Jan.

8.

The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.

Pena MJ, Pinto A, Daly A, MacDonald A, Azevedo L, Rocha JC, Borges N.

Nutrients. 2018 Nov 18;10(11). pii: E1794. doi: 10.3390/nu10111794.

9.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Meijer E, Visser FW, van Aerts RMM, Blijdorp CJ, Casteleijn NF, D'Agnolo HMA, Dekker SEI, Drenth JPH, de Fijter JW, van Gastel MDA, Gevers TJ, Lantinga MA, Losekoot M, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Wetzels JF, Zietse R, Gansevoort RT; DIPAK-1 Investigators.

JAMA. 2018 Nov 20;320(19):2010-2019. doi: 10.1001/jama.2018.15870.

10.

Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives.

de Vries JK, Levin A, Loud F, Adler A, Mayer G, Pena MJ.

Diabetes Obes Metab. 2018 Oct;20 Suppl 3:24-29. doi: 10.1111/dom.13412. Review.

11.

Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; apost hoc analysis of the PLANET trials.

Idzerda NMA, Pena MJ, Parving HH, de Zeeuw D, Heerspink HJL.

Nephrol Dial Transplant. 2018 Sep 1. doi: 10.1093/ndt/gfy159. [Epub ahead of print]

PMID:
30184238
12.

Personalized medicine in diabetic kidney disease: a novel approach to improve trial design and patient outcomes.

Idzerda NMA, Pena MJ, Heerspink HJL.

Curr Opin Nephrol Hypertens. 2018 Nov;27(6):426-432. doi: 10.1097/MNH.0000000000000447. Review.

PMID:
30095480
13.

N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.

Idzerda NMA, Persson F, Pena MJ, Brenner BM, Brunel P, Chaturvedi N, McMurray JJ, Parving HH, de Zeeuw D, Heerspink HJL.

Diabetes Obes Metab. 2018 Dec;20(12):2899-2904. doi: 10.1111/dom.13465. Epub 2018 Aug 5.

14.

Non-LDL dyslipidemia is prevalent in the young and determined by lifestyle factors and age: The LifeLines cohort.

de Vries JK, Balder JW, Pena MJ, Denig P, Smit AJ.

Atherosclerosis. 2018 Jul;274:191-198. doi: 10.1016/j.atherosclerosis.2018.05.016. Epub 2018 May 25.

PMID:
29793176
15.

Identification of an algal xylan synthase indicates that there is functional orthology between algal and plant cell wall biosynthesis.

Jensen JK, Busse-Wicher M, Poulsen CP, Fangel JU, Smith PJ, Yang JY, Peña MJ, Dinesen MH, Martens HJ, Melkonian M, Wong GK, Moremen KW, Wilkerson CG, Scheller HV, Dupree P, Ulvskov P, Urbanowicz BR, Harholt J.

New Phytol. 2018 May;218(3):1049-1060. doi: 10.1111/nph.15050. Epub 2018 Feb 20.

16.

Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.

Apperloo EM, Pena MJ, de Zeeuw D, Denig P, Heerspink HJL.

Diabetes Obes Metab. 2018 Jun;20(6):1377-1383. doi: 10.1111/dom.13226. Epub 2018 Feb 20.

17.

Changes in the abundance of cell wall apiogalacturonan and xylogalacturonan and conservation of rhamnogalacturonan II structure during the diversification of the Lemnoideae.

Avci U, Peña MJ, O'Neill MA.

Planta. 2018 Apr;247(4):953-971. doi: 10.1007/s00425-017-2837-y. Epub 2017 Dec 29.

PMID:
29288327
18.

Designer biomass for next-generation biorefineries: leveraging recent insights into xylan structure and biosynthesis.

Smith PJ, Wang HT, York WS, Peña MJ, Urbanowicz BR.

Biotechnol Biofuels. 2017 Nov 30;10:286. doi: 10.1186/s13068-017-0973-z. eCollection 2017. Review.

19.

Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease.

Pena MJ, Stenvinkel P, Kretzler M, Adu D, Agarwal SK, Coresh J, Feldman HI, Fogo AB, Gansevoort RT, Harris DC, Jha V, Liu ZH, Luyckx VA, Massy ZA, Mehta R, Nelson RG, O'Donoghue DJ, Obrador GT, Roberts CJ, Sola L, Sumaili EK, Tatiyanupanwong S, Thomas B, Wiecek A, Parikh CR, Heerspink HJL.

Kidney Int Suppl (2011). 2017 Oct;7(2):107-113. doi: 10.1016/j.kisu.2017.07.005. Epub 2017 Sep 20. Review.

20.

GEDOS-SECOT consensus on the care process of patients with knee osteoarthritis and arthoplasty.

Ruiz Iban MA, Tejedor A, Gil Garay E, Revenga C, Hermosa JC, Montfort J, Peña MJ, López Millán JM, Montero Matamala A, Capa Grasa A, Navarro MJ, Gobbo M, Loza E.

Rev Esp Cir Ortop Traumatol. 2017 Sep - Oct;61(5):296-312. doi: 10.1016/j.recot.2017.03.006. Epub 2017 Jul 6. English, Spanish.

PMID:
28689784
21.

Structural, mutagenic and in silico studies of xyloglucan fucosylation in Arabidopsis thaliana suggest a water-mediated mechanism.

Urbanowicz BR, Bharadwaj VS, Alahuhta M, Peña MJ, Lunin VV, Bomble YJ, Wang S, Yang JY, Tuomivaara ST, Himmel ME, Moremen KW, York WS, Crowley MF.

Plant J. 2017 Sep;91(6):931-949. doi: 10.1111/tpj.13628. Epub 2017 Aug 28.

22.

[Epidemiological and clinical characteristics of infants admitted to hospital due to human parechovirus infections: A prospective study in Spain].

Martín Del Valle F, Calvo C, Martinez-Rienda I, Cilla A, Romero MP, Menasalvas AI, Reis-Iglesias L, Roda D, Pena MJ, Rabella N, Portugués de la Red MDM, Megías G, Moreno-Docón A, Otero A, Cabrerizo M; Grupo de Estudio de las infecciones por enterovirus y parechovirus en niños.

An Pediatr (Barc). 2018 Feb;88(2):82-88. doi: 10.1016/j.anpedi.2017.02.009. Epub 2017 Mar 30. Spanish.

23.

Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.

Bidadkosh A, Lambooy SPH, Heerspink HJ, Pena MJ, Henning RH, Buikema H, Deelman LE.

Diabetes Care. 2017 Jun;40(6):784-792. doi: 10.2337/dc16-2175. Epub 2017 Mar 24.

PMID:
28341782
24.

Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994-2015.

Alcaide F, Peña MJ, Pérez-Risco D, Camprubi D, Gonzalez-Luquero L, Grijota-Camino MD, Dorca J, Santin M.

Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1425-1432. doi: 10.1007/s10096-017-2949-0. Epub 2017 Mar 20.

PMID:
28321580
25.

Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).

Aguilera A, Navarro D, Rodríguez-Frias F, Viciana I, Martínez-Sapiña AM, Rodríguez MJ, Martró E, Lozano MC, Coletta E, Cardeñoso L, Suárez A, Trigo M, Rodríguez-Granjer J, Montiel N, de la Iglesia A, Alados JC, Vegas C, Bernal S, Fernández-Cuenca F, Pena MJ, Reina G, García-Bujalance S, Echevarria MJ, Benítez L, Pérez-Castro S, Ocete D, García-Arata I, Guerrero C, Rodríguez-Iglesias M, Casas P, García F.

J Viral Hepat. 2017 Sep;24(9):725-732. doi: 10.1111/jvh.12700. Epub 2017 Apr 10.

PMID:
28248445
26.

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

Pena MJ, de Zeeuw D, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Kohan DE, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, Sharma S, Corringham T, Sharma K, Heerspink HJL.

Diabetes Obes Metab. 2017 May;19(5):749-753. doi: 10.1111/dom.12864. Epub 2017 Feb 22.

PMID:
28019071
27.

Downregulation of a UDP-Arabinomutase Gene in Switchgrass (Panicum virgatum L.) Results in Increased Cell Wall Lignin While Reducing Arabinose-Glycans.

Willis JD, Smith JA, Mazarei M, Zhang JY, Turner GB, Decker SR, Sykes RW, Poovaiah CR, Baxter HL, Mann DG, Davis MF, Udvardi MK, Peña MJ, Backe J, Bar-Peled M, Stewart CN Jr.

Front Plant Sci. 2016 Oct 27;7:1580. eCollection 2016.

28.

Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain.

Cabrerizo M, Díaz-Cerio M, Muñoz-Almagro C, Rabella N, Tarragó D, Romero MP, Pena MJ, Calvo C, Rey-Cao S, Moreno-Docón A, Martínez-Rienda I, Otero A, Trallero G.

J Med Virol. 2017 Mar;89(3):435-442. doi: 10.1002/jmv.24658. Epub 2016 Aug 22.

PMID:
27505281
29.

Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus.

Pena MJ, Heinzel A, Rossing P, Parving HH, Dallmann G, Rossing K, Andersen S, Mayer B, Heerspink HJ.

J Transl Med. 2016 Jul 5;14(1):203. doi: 10.1186/s12967-016-0960-3.

30.

Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease.

Pena MJ, Mischak H, Heerspink HJ.

Diabetologia. 2016 Sep;59(9):1819-31. doi: 10.1007/s00125-016-4001-9. Epub 2016 Jun 25. Review.

31.

Protein substitutes for phenylketonuria in Europe: access and nutritional composition.

Pena MJ, de Almeida MF, van Dam E, Ahring K, Bélanger-Quintana A, Dokoupil K, Gokmen-Ozel H, Lammardo AM, MacDonald A, Robert M, Rocha JC.

Eur J Clin Nutr. 2016 Jul;70(7):785-9. doi: 10.1038/ejcn.2016.54. Epub 2016 Apr 27.

PMID:
27117930
32.

Structural diversity of xylans in the cell walls of monocots.

Peña MJ, Kulkarni AR, Backe J, Boyd M, O'Neill MA, York WS.

Planta. 2016 Sep;244(3):589-606. doi: 10.1007/s00425-016-2527-1. Epub 2016 Apr 22.

PMID:
27105886
33.

Central nervous system infections caused by varicella-zoster virus.

Chamizo FJ, Gilarranz R, Hernández M, Ramos D, Pena MJ.

J Neurovirol. 2016 Aug;22(4):529-32. doi: 10.1007/s13365-016-0422-y. Epub 2016 Jan 14.

PMID:
26769041
34.

Loss of function of folylpolyglutamate synthetase 1 reduces lignin content and improves cell wall digestibility in Arabidopsis.

Srivastava AC, Chen F, Ray T, Pattathil S, Peña MJ, Avci U, Li H, Huhman DV, Backe J, Urbanowicz B, Miller JS, Bedair M, Wyman CE, Sumner LW, York WS, Hahn MG, Dixon RA, Blancaflor EB, Tang Y.

Biotechnol Biofuels. 2015 Dec 21;8:224. doi: 10.1186/s13068-015-0403-z. eCollection 2015.

35.

Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile.

Pena MJ, Almeida MF, van Dam E, Ahring K, Bélanger-Quintana A, Dokoupil K, Gokmen-Ozel H, Lammardo AM, MacDonald A, Robert M, Rocha JC.

Orphanet J Rare Dis. 2015 Dec 22;10:162. doi: 10.1186/s13023-015-0378-7.

36.

Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes.

Pena MJ, Jankowski J, Heinze G, Kohl M, Heinzel A, Bakker SJ, Gansevoort RT, Rossing P, de Zeeuw D, Heerspink HJ, Jankowski V.

J Hypertens. 2015 Oct;33(10):2123-32. doi: 10.1097/HJH.0000000000000685.

PMID:
26237555
37.

Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.

Pena MJ, de Zeeuw D, Mischak H, Jankowski J, Oberbauer R, Woloszczuk W, Benner J, Dallmann G, Mayer B, Mayer G, Rossing P, Lambers Heerspink HJ.

Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv86-95. doi: 10.1093/ndt/gfv252. Review.

PMID:
26209743
38.

Xyloglucan, galactomannan, glucuronoxylan, and rhamnogalacturonan I do not have identical structures in soybean root and root hair cell walls.

Muszyński A, O'Neill MA, Ramasamy E, Pattathil S, Avci U, Peña MJ, Libault M, Hossain MS, Brechenmacher L, York WS, Barbosa RM, Hahn MG, Stacey G, Carlson RW.

Planta. 2015 Nov;242(5):1123-38. doi: 10.1007/s00425-015-2344-y. Epub 2015 Jun 12.

PMID:
26067758
39.

Comparison of epidemiology and clinical characteristics of infections by human parechovirus vs. those by enterovirus during the first month of life.

Cabrerizo M, Trallero G, Pena MJ, Cilla A, Megias G, Muñoz-Almagro C, Del Amo E, Roda D, Mensalvas AI, Moreno-Docón A, García-Costa J, Rabella N, Omeñaca M, Romero MP, Sanbonmatsu-Gámez S, Pérez-Ruiz M, Santos-Muñoz MJ, Calvo C; study group of "Enterovirus and parechovirus infections in children under 3 years-old, Spain" PI12-00904.

Eur J Pediatr. 2015 Nov;174(11):1511-6. doi: 10.1007/s00431-015-2566-9. Epub 2015 May 16.

40.

A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.

Pena MJ, Heinzel A, Heinze G, Alkhalaf A, Bakker SJ, Nguyen TQ, Goldschmeding R, Bilo HJ, Perco P, Mayer B, de Zeeuw D, Lambers Heerspink HJ.

PLoS One. 2015 May 14;10(5):e0120995. doi: 10.1371/journal.pone.0120995. eCollection 2015.

41.

Corrigendum: Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism.

Cuskin F, Lowe EC, Temple MJ, Zhu Y, Cameron EA, Pudlo NA, Porter NT, Urs K, Thompson AJ, Cartmell A, Rogowski A, Hamilton BS, Chen R, Tolbert TJ, Piens K, Bracke D, Vervecken W, Hakki Z, Speciale G, Munōz-Munōz JL, Day A, Peña MJ, McLean R, Suits MD, Boraston AB, Atherly T, Ziemer CJ, Williams SJ, Davies GJ, Abbott DW, Martens EC, Gilbert HJ.

Nature. 2015 Apr 16;520(7547):388. doi: 10.1038/nature14334. Epub 2015 Mar 4. No abstract available.

PMID:
25739504
42.

Galactose-depleted xyloglucan is dysfunctional and leads to dwarfism in Arabidopsis.

Kong Y, Peña MJ, Renna L, Avci U, Pattathil S, Tuomivaara ST, Li X, Reiter WD, Brandizzi F, Hahn MG, Darvill AG, York WS, O'Neill MA.

Plant Physiol. 2015 Apr;167(4):1296-306. doi: 10.1104/pp.114.255943. Epub 2015 Feb 11.

43.

Peptide vaccines for cancer therapy.

Cerezo D, Peña MJ, Mijares M, Martínez G, Blanca I, De Sanctis JB.

Recent Pat Inflamm Allergy Drug Discov. 2015;9(1):38-45. Review.

PMID:
25642777
44.

Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism.

Cuskin F, Lowe EC, Temple MJ, Zhu Y, Cameron E, Pudlo NA, Porter NT, Urs K, Thompson AJ, Cartmell A, Rogowski A, Hamilton BS, Chen R, Tolbert TJ, Piens K, Bracke D, Vervecken W, Hakki Z, Speciale G, Munōz-Munōz JL, Day A, Peña MJ, McLean R, Suits MD, Boraston AB, Atherly T, Ziemer CJ, Williams SJ, Davies GJ, Abbott DW, Martens EC, Gilbert HJ.

Nature. 2015 Jan 8;517(7533):165-169. doi: 10.1038/nature13995. Erratum in: Nature. 2015 Apr 16;520(7547):388.

45.

Two Arabidopsis proteins synthesize acetylated xylan in vitro.

Urbanowicz BR, Peña MJ, Moniz HA, Moremen KW, York WS.

Plant J. 2014 Oct;80(2):197-206. doi: 10.1111/tpj.12643. Epub 2014 Sep 20.

46.

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.

Pena MJ, Lambers Heerspink HJ, Hellemons ME, Friedrich T, Dallmann G, Lajer M, Bakker SJ, Gansevoort RT, Rossing P, de Zeeuw D, Roscioni SS.

Diabet Med. 2014 Sep;31(9):1138-47. doi: 10.1111/dme.12447. Epub 2014 Apr 21.

PMID:
24661264
47.

Recent patents in autophagy and immune response.

Peña MJ, De Sanctis JB.

Recent Pat Inflamm Allergy Drug Discov. 2013 Sep;7(3):215-22. Review.

PMID:
23947691
48.

Molecular characterization of enteroviruses associated with neurological infections in Spain, 2008.

Cabrerizo M, Trallero G, Echevarría JE, Moreno-Docón A, Pena MJ, Pérez-Ruiz M, Avellón A, de Ory F; Meningitis, Encephalitis Spanish Study Group.

J Med Virol. 2013 Nov;85(11):1975-7. doi: 10.1002/jmv.23693. Epub 2013 Jul 25.

PMID:
23893817
49.

Spontaneous skull base meningoencephaloceles and cerebrospinal fluid fistulas.

Alonso RC, de la Peña MJ, Caicoya AG, Rodriguez MR, Moreno EA, de Vega Fernandez VM.

Radiographics. 2013 Mar-Apr;33(2):553-70. doi: 10.1148/rg.332125028.

PMID:
23479713
50.

Simpson-Golabi-Behmel syndrome type 1 and hepatoblastoma in a patient with a novel exon 2-4 duplication of the GPC3 gene.

Mateos ME, Beyer K, López-Laso E, Siles JL, Pérez-Navero JL, Peña MJ, Guzmán J, Matas J.

Am J Med Genet A. 2013 May;161A(5):1091-5. doi: 10.1002/ajmg.a.35738. Epub 2013 Mar 5.

PMID:
23463737

Supplemental Content

Support Center